EconomyHims & Hers launches peptide treatments, while acknowledging more needs to be learned about efficacy
The telehealth company will offer compounded sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine. None of the treatments has FDA approval.
Hims & Hers launches peptide treatments, while acknowledging more needs to be learned about efficacy
Economy